statistiche ricercatore

ROSETI, CRISTINA

Distribuzione geografica

Continente	#
NA - Nord America	1.457
EU - Europa	1.123
AS - Asia	160
Continente sconosciuto - Info sul continente non disponibili	9
OC - Oceania	2
SA - Sud America	1
Totale	2.752

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	1.457
IT - Italia	762
UA - Ucraina	120
SE - Svezia	84
TR - Turchia	79
IE - Irlanda	54
VN - Vietnam	47
DE - Germania	35
CN - Cina	28
GB - Regno Unito	24
CZ - Repubblica Ceca	20
EU - Europa	9
FR - Francia	7
AT - Austria	5
BE - Belgio	3
FI - Finlandia	3
NL - Olanda	3
AU - Australia	2
HK - Hong Kong	2
IN - India	2
JP - Giappone	2
CH - Svizzera	1
CL - Cile	1
ES - Italia	1
MD - Moldavia	1
Totale	2.752

Salva come PNG Salva come JPEG

Città	#
Milan	490
Fairfield	226
Chandler	123
Woodbridge	117
Ashburn	114
Jacksonville	97
Houston	96
Seattle	90
Cambridge	88
Wilmington	79
Nyköping	61
Dearborn	58
Princeton	56
Como	55
Dublin	52
Ann Arbor	47
Izmir	43
Rome	39
Kocaeli	36
Dong Ket	30
Chicago	21
New York	12
Ogden	12
Olomouc	12
Norwalk	11
San Diego	11
Boardman	7
Gavirate	7
London	7
Nanjing	5
Vienna	5
Ancona	4
Busto Arsizio	4
Frankfurt am Main	4
Jinan	4
Los Angeles	4
Washington	4
Beijing	3
Brno	3
Brussels	3
Casnate Con Bernate	3
Dordrecht	3
Garbagnate Milanese	3
Hefei	3
Kilburn	3
Magnago	3
Mentana	3
Padova	3
Redmond	3
Chengdu	2
Chiswick	2
Helsingborg	2
Helsinki	2
Hong Kong	2
Monza	2
Munich	2
New Bedfont	2
Omegna	2
Palermo	2
Perugia	2
Prescot	2
Pune	2
Strasbourg	2
Sydney	2
Terzigno	2
Tokyo	2
Varese	2
Vicenza	2
West Jordan	2
Acton	1
Baotou	1
Dicomano	1
Falkenstein	1
Florence	1
Hounslow	1
Lappeenranta	1
Marche	1
Nervesa della Battaglia	1
San Jose	1
Shaoxing	1
Shenyang	1
Tappahannock	1
Valfenera	1
Wandsworth	1
Wenzhou	1
Wuhan	1
Zhengzhou	1
Zurich	1
Totale	2.226

Salva come PNG Salva come JPEG

Nome	#
A novel GABAergic dysfunction in human Dravet syndrome	141
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy	138
Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study	133
TRP channels expression in Chronic Low Back Pain	125
Cannabis in Epilepsy: from clinical practice to basic research focusing on the possible role of cannabidivarin	124
Changes in the sensitivity of GABAA current rundown to drug treatments in a model of temporal lobe epilepsy	123
Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions	118
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors	115
Modulation of GABAA receptors in the treatment of epilepsy	113
Fractalkine/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy	111
Physiological characterization of human muscle acetylcholine receptors from ALS patients	104
Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex	104
A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy	104
Riluzole blocks human muscle acetylcholine receptors	103
Novel approaches to study the involvement of α7-nAChR in human diseases	101
GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis	98
Erythropoietin Increases GABA A Currents in Human Cortex from TLE Patients	96
GABA(A)-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABA(A) "phasic" receptors	92
Is Betaine a substrate also for GABA transporter 1 (GAT1)?	87
Functional characterization of Atlantic salmon (Salmo salar L.) PepT2 transporters	84
Characterization of transport activity of SLC11 transporters in Xenopus laevis oocytes by fluorophore quenching	83
The Lepidopteran KAAT1 and CAATCH1: orthologs to understand structure-function relationships in mammalian SLC6 transporters	81
Enhancement of GABA(A)-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy	80
Blockage of A(2A) and A(3) adenosine receptors decreases the desensitization of human GABA(A) receptors microtransplanted to Xenopus oocytes	76
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease	60
The role of LRRK2 in the modulation of the glutamate transporter EAAT2 in Parkinson's disease	58
The “www” of Xenopus laevis Oocytes: The Why, When, What of Xenopus laevis Oocytes in Membrane Transporters Research	48
Interview with Cristina Roseti, 2013 Morris-Coole/Epilepsia prize winner (interview by Gary Mathern and Astrid Nehlig)	38
Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism	35
Betaine-The dark knight of the brain	26
The interaction of bile acids with dopamine transporter heterologously expressed in Xenopus laevis oocytes	16
Membranes and synaptosomes used to investigate synaptic GABAergic currents in epileptic patients	3
Totale	2.818

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	11.759
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	11.759

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	564	22	28	35	111	40	77	75	61	47	29	12	27
2020/2021	438	10	36	12	33	27	29	36	26	60	70	53	46
2021/2022	308	44	36	6	18	9	4	35	18	26	27	49	36
2022/2023	424	39	5	40	14	34	82	12	68	64	25	24	17
2023/2024	852	131	144	139	146	162	40	7	12	18	8	12	33
2024/2025	24	24	0	0	0	0	0	0	0	0	0	0	0
Totale													2.818